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Abstract
Background: Cancer remains one of the most dreaded diseases causing an astonishingly high
death rate, second only to cardiac arrest. The fact that conventional and newly emerging treatment
procedures like chemotherapy, catalytic therapy, photodynamic therapy and radiotherapy have not
succeeded in reverting the outcome of the disease to any drastic extent, has made researchers
investigate alternative treatment options. The extensive repertoire of traditional medicinal
knowledge systems from various parts of the world are being re-investigated for their healing
properties. This study progresses in the direction of identifying component(s) from Nigella sativa
with anti cancer acitivity. In the present study we investigated the efficacy of Organic extracts of
Nigella sativa seed powder for its clonogenic inhibition and induction of apoptosis in HeLa cancer
cell.
Results: Methanolic, n-Hexane and chloroform extracts of Nigella sativa seedz effectively killed
HeLa cells. The IC50 values of methanolic, n-hexane, and chloroform extracts of Nigella sativa were
2.28 μg/ml, 2.20 μg/ml and 0.41 ng/ml, respectively. All three extracts induced apoptosis in HeLa
cells. Apoptosis was confirmed by DNA fragmentation, western blot and terminal transferase-
mediated dUTP-digoxigenin-end labeling (TUNEL) assay.
Conclusion:  Western Blot and TUNEL results suggested that Nigella sativa seed extracts
regulated the expression of pro- and anti- apoptotic genes, indicating its possible development as
a potential therapeutic agent for cervical cancer upon further investigation.
Background
Around one quarter of deaths in the US are accounted for
by Cancer. According to the American Cancer Society, on
an average, 559,312 people die of the disease each year [1]
despite tremendous efforts to find methods of control and
cure. Thus, not surprisingly, every fourth citizen of a
developed country will be stricken sometime during his/
her life and approximately 400 new incidents emerge per
100,000 people annually [2]. The statistics released by
WHO in 2008 and GLOBOCAN indicate that there is a
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high likelihood of developing countries approaching the
same incident rates of cancer as developed ones, because
of life style changes, average age of the population,
tobacco usage, etc [3,4]. In a scenario where conventional
medicine has failed to develop techniques that could
reduce the incidence of death due to cancer, complemen-
tary and alternative medicine (CAM) is slowly emerging as
an option. A variety of ingredients of traditional medi-
cines and herbs are being widely investigated in several
parts of the world to analyze their potential as therapeutic
agents [5-7]. According to the National Institute of
Health's National Centre for Alternative and Complemen-
tary medicine, around 36% of people in the US use alter-
native medicine in some form or the other. Several studies
indicate that a majority of cancer patients use CAM exten-
sively as a mode of treatment or as a means to reduce the
side effects of conventional treatment methods [8-10].
There are a number of alternative medicine systems based
on traditional theories and philosophy that have origi-
nated in specific geographical areas and evolved over the
years. The most widely practiced of these include the
Unani, Ayurveda & Siddha and the Chinese system of med-
icine that have originated from the Arab, India and China
respectively. These medicinal systems have identified
more than 700 individual herbal extracts as well as several
drug preparations which claim to treat and/or prevent sev-
eral diseases including cancer [11].
Apoptosis an active physiological process resulting in cel-
lular self-destruction of unwanted cells is absent in cancer
cells. Apoptosis is characterised by distinct morphologic
changes, including cell shrinkage, membrane blebbing,
chromatin condensation, DNA fragmentation, and the
formation of apoptotic bodies [12]. Bcl-2 family proteins
determine whether a cell lives or dies, by controlling the
release of mitochondrial apoptogenic factors, which are
associated with death proteases, called caspases [13]. Cas-
pases, a class of cysteine proteases, are central players in
the apoptotic process that trigger a cascade of proteolytic
cleavage events [14]. The activation of caspase-3 is an
important downstream event in apoptosis [15]. p53, a
tumor suppressor gene, helps regulate the cell cycle. It
plays a key role in ensuring that damaged cells are
destroyed by apoptosis (programmed cell death). p53 is
the most commonly mutated gene associated with cancer.
The regulation of apoptosis in normal and malignant cells
has become an area of intensive study in cancer research
[16]. The therapeutic application of apoptosis is currently
being considered as a model for the development of anti-
tumour drugs [17]. It is therefore essential to identify
novel apoptosis-inducing compounds that are candidate
anti-tumour agents.
In present study we chose to investigate the extracts of Nig-
ella sativa seed (NS) for testing its in vitro apoptotic activ-
ity. It is an annual herb belonging to the family
Ranunculaceae and is commonly known as black cumin
and is a natural food additive in India and many parts of
Asia. The seeds of NS are the source of active ingredient of
this plant. In the Unani system, it is regarded as one of the
greatest forms of healing medicine available.
The bioactivity of the NS seeds has been investigated both
in vitro as well as in vivo for a number of therapeutic
properties like antioxidant, antihistaminic, anti inflam-
matory, immune-modulatory, anti viral, anti helimenthic,
anti bacterial [18] and its clononogenic effect on PC-3
cells [19]. However, its anti tumor properties have to be
researched further.
Cervical cancer forms an important part of cancer sub-
types among women and is more common in Hispanic
and African-American women than in Caucasians. It is the
fifth most common type of cancer among women with
471,000 new cases each year with 11,070 cases in US in
2008 and 3,870 deaths according to the data released by
the National Cancer Institute. Considering the signifi-
cance of this cancer sub-type accounting to a death every
2 minutes, we used HeLa cell lines to analyze the antican-
cer activity of the NS seed extract and sought to investigate
the ability of NS to induce apoptosis and to determine the
biochemical mechanisms underlying apoptosis in HeLa
cells. To determine the species' antiproliferative activity,
we examined the effects of various solvent fractions on
cell viability by clonogenic inhibition assay. Induction of
apoptosis was assessed by DNA fragmentation, TUNEL
assay and western blot for the expression of the anti-apop-
totic protein Bcl-2 & bcl-XL and of the pro-apoptotic pro-
teins caspase-9, caspase-8 and caspase-3 and p53. The
results led us to hypothesize that certain bioactive com-
pounds in NS seeds might be capable of effectively caus-
ing death of cancer cells by up-regulating the expression of
certain pro-apoptotic gene and simultaneously down-reg-
ulating the expression of anti-apoptotic genes.
Results and Discussion
NS extract-induced clonogenic inhibition of HeLa cells
The methanolic extract (IC50 2.28 μg/mL) (Fig 1A), n-hex-
ane extract (IC50 2.20 μg/mL), (Fig 1B) and chloroform
extract (IC50 0.41 ng/mL) (Fig 1C) significantly inhibited
the growth of HeLa cells. Further, all three extracts (n-hex-
ane, methanolic and chloroform) produced significant
clonogenic inhibition of HeLa cells. The IC50  values
clearly indicated that the chloroform extract had a much
more potent effect on HeLa cells than the n-hexane and
methanolic extracts.Cancer Cell International 2009, 9:29 http://www.cancerci.com/content/9/1/29
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Quantification of Apoptosis by DNA fragmentation and 
TUNEL assay
Apoptosis is a form of programmed cell death character-
ized by cytoplasmic condensation, plasma membrane
blebbing and nuclear pycnosis, leading to nuclear DNA
breakdown into multiples of ~200 bp oligonucleosomal
size fragments. The detection of apoptosis in cultured cells
relies heavily on techniques involving the extraction of
nuclear DNA and characterization of such oligonucleo-
somal ladders by gel electrophoresis and detection of
DNA damage by end labeling using terminal transferase-
mediated dUTP-digoxigenin-end labeling (TUNEL). HeLa
cells were treated with respective IC50 concentration of NS
seed extracts as follows: chloroform extract at 0.41 ng/ml,
the n-hexane extract at 2.20 μg/ml and the methanolic
extract at 2.28 μg/ml to determine whether the bioactive
compounds of NS seeds induced HeLa cell death via
apoptosis or by necrosis. HeLa cells treated with these
extracts showed active apoptosis after 24 hours of treat-
ment; the increase in apoptosis over the untreated popu-
lation was 21.1% in methanolic extract treated cells, 30%
n-hexane extract treated cells and 42% chloroform extract
treated cells (Fig 2). Apoptosis was determined by micro-
scopic based TUNEL examination and DNA fragmenta-
tion (Fig 3).
Altered Apoptotic Gene Activity and Caspase activation by 
NS Seed extract treatment in HeLa Cells
To determine the mechanism of NS-induced apoptosis,
the expression of anti- and pro-apoptotic proteins follow-
ing NS treatment was examined by western blotting. It was
clear from western blot results that the expression of p53,
caspase-3,  -8  and  -9  was higher in chloroform extract
treated cells, followed by n-hexane and methanolic
extracts treated cells compared to respective controls.
However bcl-2 and bcl-XL were down regulated in n-hex-
ane extract treated cells compared to chloroform and
methanolic extract treated and untreated cells (Fig 4). This
suggested that n-hexane contains some compounds
which down regulates the expression of bcl-2 and bcl-XL.
Similarly, chloroform, n-hexane and methanolic extracts
also contained certain compounds which up regulate the
expression of p53 (Fig 5), caspase-3,-8 and -9 (Fig 6).
A NS-Methanolic Extracts induced Clonogenic inhibition in  HeLa cells Figure 1
A NS-Methanolic Extracts induced Clonogenic inhibi-
tion in HeLa cells. 1B. NS n-haxane Extracts induced Clo-
nogenic inhibition in HeLa cells. 1C: NS-Chloroform Extract 
induced Clonogenic inhibition in HeLa cells
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NS extracts induced apoptosis in HeLa cells Figure 2
NS extracts induced apoptosis in HeLa cells. The bar 
graphs show the percentage of TUNEL-positive cells. Apop-
tosis in the treated cells was normalized to the baseline 
apoptosis in the untreated cells. The data shown are the 
means from two independent experiments.Cancer Cell International 2009, 9:29 http://www.cancerci.com/content/9/1/29
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Conclusion
The drug discovery process is becoming more and more
complex and capital-intensive, and it calls for systematic
and critical review of methods and approach towards the
entire process, a need to rediscover the discovery process
afresh.
The Indian Systems of Medicine are in the list approved by
the National Council for Alternative Medicine (NCAM),
USA, although most of these drugs that claim to cure var-
ious ailments are yet to be validated scientifically. Accord-
ing to Parasnis [20], the full potential of Ayurveda can be
realized only by subjecting the ayurvedic drugs to modern
investigation techniques. Further acceptance of any clini-
cal trial depends on whether it satisfies modern pharma-
cological and statistical standards. Unfortunately, most
people practicing Ayurveda decline to adopt modern
research techniques for evaluation of the formulations
used in the practice. This holds good for other traditional
medical practitioners like those of Siddha and Unani
medicinal systems too. Scientific validation will not only
popularize these medicines in India but also render them
acceptable, in some form, to people in other parts of the
world. Considering the fact that several diseases do not
have an ultimate answer in the conventional system
whether in native regions or throughout the world, an
effort to recognize the potential of alternative and combi-
national treatment systems validated through universally
acceptable methods could prove to be very beneficial for
the human community at large.
Screening of medicinal plants for potential anticancer
properties has increased greatly over the past few decades.
For instance, the US National Cancer Institute has imple-
mented a large-scale project of acquisition and screening
of compounds isolated from medicinal plants originating
in various parts of the world. These medicinal plants are
identified based on ethnopharmacological, chemosys-
temic and ecological information.
Therefore, there is a need for more effective anticancer
agents since the most common tumors in adults are resist-
ant to almost all presently available anticancer drugs and
the majority of the available drugs have limited anti-solid
tumor activity [21].
Apoptosis is an active physiological process resulting in
cellular self-destruction that involves specific morpholog-
ical and biochemical changes in the nucleus and cyto-
plasm [22]. Agents that suppress the proliferation of
malignant cells by inducing apoptosis may represent a
useful mechanistic approach to both cancer chemopre-
DNA laddering Figure 3
DNA laddering: DNA fragmentation on 1% Agarose Gel 
Electrophoresis shows; Lane 1 100 bp marker, Lane 2 
untreated cells, Lane 3 Chloroform extract treated cells, 
Lane 4 n-hexane extract treated cells and Lane 5 methanolic 
extract treated cells.
Expression of anti-apoptotic genes; bcl-2 and bcl-XL in HeLa  cells treated with methanolic, choloroform and n-haxane  extract Figure 4
Expression of anti-apoptotic genes; bcl-2 and bcl-XL 
in HeLa cells treated with methanolic, choloroform 
and n-haxane extract. The graph shows the intensity of 
bands (ImageJ sofware).Cancer Cell International 2009, 9:29 http://www.cancerci.com/content/9/1/29
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vention and chemotherapy. While many anticancer
agents have been developed, unfavourable side effects and
resistance are serious problems [23]. Thus, there is grow-
ing interest in the use of plant materials for the treatment
of various cancers and the development of safer and more
effective therapeutic agents [24]. NS seeds have been used
as a folk remedy for several diseases including cancer
without any understanding of the underlying mecha-
nisms. In this paper, we investigated the influence of NS
seed on cellular proliferation and apoptosis using various
extract fractions. The NS induced apoptosis in HeLa cells,
indicating that it may be used as a therapeutic agent for
human cervical cancer. In general, apoptosis is controlled
by the complex interplay between regulatory proteins
from the Bcl-2 family [25]. These pro- and anti-apoptotic
proteins are key regulators of the intrinsic pathway of
apoptosis, controlling the point of no return and setting
the threshold for engagement of the death machinery
[26]. Previous reports have shown that the ratio of Bax to
Bcl-2 determines, in part, the susceptibility of cells to
death signals [27]. Therefore, Bcl-2 proteins have emerged
as an attractive target for the development of novel anti-
cancer drugs [28]. Changes in the Bcl-2/Bax ratio have
been reported to be caused by downregulation of Bcl-2
and slight downregulation of Bax [29], downregulation of
Bcl-2 and upregulation of Bax [30,31], and downregula-
tion of Bcl-2 with no change in the level of Bax [32]. In
this study, we demonstrated that Bcl-2 and bclXL expres-
sion was significantly inhibited while p53 and caspase -3,-
8 &-9 expression was markedly increased in a concentra-
tion-dependent manner. Our results suggest that the NS
induced apoptosis by regulating apoptotic genes.
The mechanism of action of many anticancer drugs is
based on their ability to induce apoptosis [33,34]. Hence
we were interested to identify if cancer cells treated with
various organic extracts of N. sativa used apoptosis as their
mode of cell death. This was investigated by studying dis-
tinct morphological features (nuclear chromatin conden-
Expression of caspase -3, -8 and -9 in HeLa cells treated with  methanolic, choloroform Figure 5
Expression of caspase -3, -8 and -9 in HeLa cells 
treated with methanolic, choloroform. and n-haxane 
extract. The graph shows the intensity of bands (ImageJ 
sofware).
Expression of pro-apoptotic gene, p53 in HeLa cells treated  with methanolic, choloroform Figure 6
Expression of pro-apoptotic gene, p53 in HeLa cells 
treated with methanolic, choloroform. and n-haxane 
extract. The graph shows the intensity of bands (ImageJ 
sofware).Cancer Cell International 2009, 9:29 http://www.cancerci.com/content/9/1/29
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sation, fragmentation of nuclear material) and molecular
features (expression of certain crucial genes).
The NS seed powder was subjected to three different
organic extractions with increasing polarity viz. methanol,
chloroform and n-hexane. This was to reduce the concen-
tration of the NS seed components in each extract, so that
the potent compound(s) can be identified. These extracts
regulated the expression of specific target genes. It was
found that the chloroform extract led to over expression
of pro-apoptotic genes while n-hexane and methanolic
extracts led to down regulation of anti-apoptotic genes
when compared to respective controls. After sufficient
analysis, we could conclude that the NS extracts contain
potent component(s) which have the ability to induce
apoptosis through caspase and p53 pathway in HeLa cells.
However, further studies are required to find the exact
compound(s) and their structure(s) as well as to find
whether the same extract/compound(s) are also capable
of regulating the expression of the same genes in other
cancer cell types. In addition, it was observed that the n-
haxane extract down- regulated the expression of bcl-2
and bcl-XL and the methanolic and chloroform extract
inhibited the expression of bcl-2, though to a smaller
extent.
Efforts towards finding a practical solution in combating
this dreadful disease could prove to be of paramount
importance. There is no paucity on the availability of
umpteen numbers of medicinal plants known to regional
communities practicing indigenous healing techniques,
which can on scientific evaluation provide an alternative
to the presently available options that do not go without
severe and painful side-effects. Many herbs have been
evaluated in clinical studies and are currently being inves-
tigated phytochemically to understand their tumouricidal
action against the insidious nature cancer.
Ayurvedic therapy has been found to cure these chronic
diseases like caner better, which are previously not ame-
nable to treatment by western medical practices [35]. This
traditional Indian medicine with its evolution through
centuries has always fascinated practitioners and research-
ers for its applications in cancer treatment on a scientifi-
cally proven research background.
Herbal decoctions consisting of multiple herbs each pos-
sessing tremendous potential for a cancer cure are com-
monly used in Ayurveda. These formulations are reported
to work on multiple biochemical pathways and are capa-
ble of influencing several organ systems simultaneously.
The benefit of a herbal decoction is that it can nourish the
body as a whole by supporting various organ systems.
More importantly as it has no synthetic part to it, there is
very less likelihood of an unexpected adverse effect. Many
of the herbs have been scientifically-proven for anti-can-
cerous properties and are used for the treatment of various
cancers [36,37]. They include the Vinca alkaloids (from
the Madagascar periwinkle, Vinca rosea), irinotecan (from
Camptotheca accuminata) and paclitaxol (from the Pacific
yew tree Taxus brevifolia). Future research in this area
would help in the identification of safe and effective anti-
cancer drugs.
However, the potent extracts should be tested on several
other cancer cell lines, biochemical and molecular studies
carried out using the extracts in animal models to estab-
lish their therapeutic efficacy as well as toxicity, and the
most potent extracts subjected to HPLC and GC&MS anal-
yses to identify and characterize the efficacious phytother-
apeutic and/or bioactive compound(s) in NS.
Materials and methods
Preparation of organic extract
Air dried NS seeds were pulverized using a milling
machine and extracted with Methanol, n-hexane, Chloro-
form, using the Soxhlet apparatus, as represented in the
flow chart (Fig 7). Each organic phase was later evapo-
rated under reduced pressure to obtain the residue, using
a rotary evaporator to dryness in order to obtain the
respective lyophilized powder/paste, weight and required
quantity was dissolved in Dimethyl Sulfoxide (DMSO).
Maintenance of HeLa cell line
HeLa cells were procured from the National Centre of Cell
Sciences (NCCS), Pune, India. Cell lines were maintained
and propagated in 90% Dulbecco's Modified Eagle's
Medium (DMEM) containing 10% fetal bovine serum
(FBS) and 1% penicillin/streptomycin. Cells were cul-
tured as adherent monolayer and maintained at 37°C in
a humidified atmosphere of 5% CO2. Cells were harvested
Extraction and partitioning of bioactive compounds of N.  sativa Figure 7
Extraction and partitioning of bioactive compounds 
of N. sativa.Cancer Cell International 2009, 9:29 http://www.cancerci.com/content/9/1/29
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after subjecting them to brief trypsinization. All Chemi-
cals were research grade.
Cell Viability Assay
Cell viability was assayed where and as required by trypan
blue exclusion test [38] with slight modifications. The via-
bility of cells was found to fall between 90-95%.
Colonogenic Inhibition Assay
The Colonogenic inhibition assay was performed as
described previously by us [19]. Briefly, two different cell
concentrations in quadruplet sets were used for one dose
point. After incubation for 13 days, each flask was stained
with crystal violet and the colonies containing more than
50 cells were counted. The surviving fraction was calcu-
lated by the following equation, and then normalized by
cell multiplicity:
(Where PE is the plating efficiency).
Determination of IC50 Concentration
The IC50 value (the concentration of the drug which is
capable of bringing about 50% inhibition of colony for-
mation) of the drug used for treatment was determined by
plotting a graph with Survival fraction (Y-axis) against the
concentrations of the extracts (X-axis) [Fig 1A, B &1C].
Analysis of DNA Fragmentation
HeLa cells were treated with respective concentration
(IC50) of each extract for 24 hours and then harvested.
Genomic DNA was extracted by standard salting out
method with slight modification [21] and was electro-
phoresed on 1.8% agarose for DNA fragmentation which
allows to determine the amount of DNA that is degraded
upon treatment of cells with certain agents.
TUNEL Assay
To quantify apoptosis, the ApopTag™ in situ apoptosis
detection kit (Oncor, Gaithersburg, MD) was used as per
the instructions of the manufacturer. The ApopTag kit
detects DNA strand breaks in single cells by terminal
transferase-mediated dUTP-digoxigenin-end labeling
(TUNEL). Briefly, cells were seeded in chamber slides and
the next day they were exposed to each organic extracts.
After 24 hrs the DNA was tailed with digozigenin-dUTP
and cojugated with an anti-digoxigenin fluorescein. The
cells were then counterstained with propidium iodide and
antifade. The stained cells were observed using Carl-Zeiss
epifluorescence microscope using triple band-pass filter.
To determine the percentage of cells indicating apoptosis,
a total of 1000 cells were counted in each experiment.
Western Blot Analysis
After treatment, the cells were collected and washed twice
with cold PBS. The cells were then lysed in lysis buffer (50
mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 2
mM EDTA, 1 mM EGTA, 1 mM NaVO3, 10 mM NaF, 1
mM DTT, 1 mM PMSF, 25 lg/ml aprotinin, and 25 lg/ml
leupeptin) and kept on ice for 30 min. The lysates were
then centrifuged at 12,000 g at 4°C for 20 min; the super-
natants were stored at -70°C until use. The protein con-
centration was determined by the Bradford method.
Aliquots of the lysates (30 μg of protein) were separated
by 12% SDS-PAGE and transferred onto a nitrocellulose
membrane using transfer buffer (192 mM glycine, 25 mM
Tris-HCl, pH 8.8, and 20% methanol [v/v]). After block-
ing with 5% non-fat dried milk, the membrane was incu-
bated for 2 h with primary antibodies, followed by 30 min
with secondary antibodies in milk containing Tris-buff-
ered saline (TBS) and 0.5% Tween. Anti-human p53, cas-
pase-3, caspase-8, -caspase-9, -Bcl-2, and bcl-XL antibodies
were used at a 1:1000 dilution as the primary antibodies,
while horseradish peroxidase-conjugated horse anti-rab-
bit IgG (Sigma Chemicals, USA) was used at a 1:5000
dilution as the secondary antibody. The membrane was
then exposed and protein bands were detected using
Enhanced Chemiluminescence.
Statistical analysis
The results of each series of experiments (performed in
triplicates) are expressed as the mean values ± standard
deviation of the mean (SD).
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